| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |